Clin2
NCT06752759Possibly a fitRecruiting

Ketamine mist for depression

Severe DepressionModerate DepressionKetamineMidazolamPeripheral Nervous System AgentsCentral Nervous System AgentsNeurotransmitter AgentsPhysiologic Effects of Drugs

Part of Mental health, Pain clinical trials.

This trial tests if a ketamine mist you breathe in can help treat moderate to severe depression. It is for adults who are not helped enough by other treatments.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
40 people
Ages
18 years to 88 years
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have been diagnosed with moderate to severe major depression.
  • Your depression is currently at least moderately severe.
  • You do not have bipolar disorder or psychosis.
  • You have not used illegal drugs (besides cannabis) in the past 3 months.
  • You do not have uncontrolled high blood pressure or heart failure.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07139106Not yet recruiting· Phase 4
Ketamine for suicidal thoughts in depression

This study tests whether ketamine can help reduce suicidal thoughts in people with depression. It also looks at how ketamine affects a brain receptor that may be linked to mood and stress, to learn why it might help.

New York, New York
NCT06788249Recruiting· Early Phase 1
Ketamine for treatment-resistant depression brain study

This trial tests whether a single dose of ketamine can quickly improve depression by studying brain chemical changes using MRI. It's for people with treatment-resistant depression who haven't used ketamine before.

Philadelphia, Pennsylvania
NCT07307768Not yet recruiting· Phase 1
Ketamine treatment study for severe major depression

This study tests how a single dose of ketamine affects certain brain and body markers in people with severe depression. It aims to find better ways to predict who will respond to ketamine, which may help personalize depression treatment in the future.

New York, New York
NCT06213324Recruiting· Phase 4
Ketamine's effects on brain circuits in depression

This trial studies how ketamine affects brain circuits in people with depression compared to healthy volunteers. It involves a single infusion of ketamine and brain scans before and after.

New York, New York
NCT06559826Recruiting· Phase 2
Ketamine therapy with or without talk for depression

This study compares ketamine alone to ketamine combined with psychotherapy for treating depression. It may help if you have moderate to severe depression and want to see if adding talk therapy improves results.

New York, New York
NCT05327699Recruiting· Early Phase 1
Ketamine study for depression with reduced pleasure

This early-phase study tests whether ketamine can help people with major depression who have trouble feeling pleasure. It also studies how the brain may change in response to stress, to better understand who might respond to treatment.

Atlanta, Georgia

Hear when a new Ketamine trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.